Mylotarg and haematocrit decreased Patient Reports February 12, 2012

Mylotarg Side Effects Report #5213873-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2007. Male patient, 72 years of age, weighting 190.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood magnesium increased, blood thyroid stimulating hormone increased, carbon dioxide decreased, haematocrit decreased, haemoglobin decreased, myocardial infarction, platelet count decreased, sinus tachycardia. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TRISENOX, LIPITOR, PRINIVIL, PRILOSEC, IMDUR, ATIVAN, ZOLOFT, LOPRESSOR. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5119943-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, child 8 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, blood pressure decreased, coagulopathy, haematocrit decreased, haemoglobin decreased, platelet count decreased, weight increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with KEITEN, MEROPEN, MINOCYCLINE HYDROCHLORIDE, VFEND, LASIX, ACYCLOVIR, MORPHINE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5217521-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, haematocrit decreased, haemoglobin decreased, peptic ulcer

, white blood cell count decreased. Mylotarg dosage: 6 MG/M^2 1X PER DAY INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, MUCOSTA, DIFLUCAN, POLYMYXIN B SULPHATE, CLARITHROMYCIN, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5109798-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count decreased, blood albumin decreased, blood lactate dehydrogenase increased, blood urea decreased, c-reactive protein increased, fibrin degradation products increased, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 9 MG/M2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with FIRSTCIN, TIENAM, OMEGACIN, FUNGUARD, PRODIF, FARESTON, RISPERDAL. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5197491-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 20, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count decreased, blood lactate dehydrogenase increased, blood urea decreased, fibrin degradation products increased, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, myeloid leukaemia, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with FIRSTCIN, TIENAM, OMEGACIN, FUNGUARD, PRODIF, FARESTON, RISPERDAL. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #4914259-5
Mylotarg side effect was reported by a Health Professional from JAPAN on Feb 07, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, cellulitis

, chills, disease progression, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ANASTROZOLE, FAMOTIDINE, LEVOFLOXACIN, BIOFERMIN R, SULFAMETHOXAZOLE, FLUCONAZOLE. Patient died.

Mylotarg Side Effects Report #5220632-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, depression

, haematocrit decreased, haemoglobin decreased, hepatic function abnormal, insomnia, intraocular pressure increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with INSULIN, POLYMYXIN B SULPHATE, ITRACONAZOLE, FAMOTIDINE, MUCOSTA, PREDNISOLONE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5019629-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cerebral haemorrhage, coagulopathy, disease progression, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, PRODIF, MAXIPIME, BICARBONATE, OXYCONTIN, MAGNESIUM OXIDE, URSO. Patient died.

Mylotarg Side Effects Report #5202094-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 25, 2006. Female patient, 29 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bronchopulmonary aspergillosis, condition aggravated, haematocrit decreased, haemoglobin decreased, herpes zoster, immunosuppression, platelet count decreased, pleural effusion. Mylotarg dosage: 9 MG/M^2 1 X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ETOPOSIDE, VFEND, CEFTAZIDIME, AMIKACIN SULPHATE, MEROPEN, TARGOCID, SULFAMETHOXAZOLE. Patient recovered.

Mylotarg Side Effects Report #5713144-9
Mylotarg side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, weighting 74.96 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, constipation

and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, lymphocyte count increased, neutrophil count decreased, red blood cell count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, FUNGUARD, MAXIPIME, MAGNESIUM OXIDE, URSO. Patient recovered.

Mylotarg Side Effects Report #5158526-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 09, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal haemorrhage, haematocrit decreased, haematuria, haemoglobin decreased, platelet count decreased, urinary tract infection

, white blood cell count decreased. Mylotarg dosage: 7 MG/M^2 1 PER 1 DAY. During the same period patient was treated with TOWAMIN, CALCIUM CARBONATE, SELBEX, SULFAMETHOXAZOLE, MAGNESIUM OXIDE, MUCOSTA. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #4867657-2
Mylotarg side effect was reported by a Physician from UNITED STATES on Apr 28, 1999. Male patient, 82 years of age, weighting 194.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: agitation, chills, condition aggravated, confusional state, fatigue, haematocrit decreased, haemorrhage intracranial, hypotension, leukopenia. Mylotarg dosage: 9 MG/M (2), INTRAVENOUS. During the same period patient was treated with CEFTAZIDIME, VANCOMYCIN, AZITHROMYCIN, PEPCID, FUROSEMIDE, NYSTATIN. Patient was hospitalized. Patient died on 02/17/1999.

Mylotarg Side Effects Report #4869804-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2005. Male patient, 81 years of age, weighting 152.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, white blood cell count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, FLOMAX, ACYCLOVIR, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4620730-6
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 15, 2005. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood glucose increased, blood potassium decreased, confusional state, csf protein increased, febrile neutropenia, haematocrit decreased, haemoglobin decreased, headache

. Mylotarg dosage: unknown. During the same period patient was treated with FOLIC ACID, ACYCLOVIR, NORVASC, ACCUPRIL, ATENOLOL, VITAMINS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4631422-1
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 28, 2005. Male patient, 77 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood calcium decreased, blood glucose increased, blood potassium decreased, csf protein increased, febrile neutropenia, haematocrit decreased, haemoglobin decreased, headache

. Mylotarg dosage: unknown. During the same period patient was treated with FOLIC ACID, ACYCLOVIR, NORVASC, ACCUPRIL, ATENOLOL, VITAMINS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4943877-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 01, 2006. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood pressure diastolic decreased, body temperature decreased, fall

, haematocrit decreased, haemoglobin decreased, head injury, malignant neoplasm progression, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with AMLODIPINE BESYLATE, BEPRIDIL HYDROCHLORIDE MONOHYDRATE, DIOVAN. Patient died.

Mylotarg Side Effects Report #5147197-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 02, 2006. Female patient, 76 years of age, was diagnosed with acute myeloid leukaemia, pneumonia

, neutrophil count decreased and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood urea increased, haematocrit decreased, haemoglobin decreased, hypernatraemia, liver disorder, neutrophil count decreased, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CIPROXAN, NEUPOGEN, OMEGACIN, VANCOMYCIN, STRONG NEO MINOPHAGEN C, VFEND. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4763886-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 25, 2005. Female patient, 76 years of age, weighting 104.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with HYDROXYUREA. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4910435-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 27, 2006. Male patient, 76 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, body temperature decreased, cryptogenic organizing pneumonia, haematocrit decreased, hypotension, hypovolaemia, neutropenia, respiratory rate increased, sepsis

. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TRISENOX, KETOCONAZOLE, ACYCLOVIR, ATENOLOL, SYNTHROID, VITAMINS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5023688-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2006. Male patient, 76 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count increased, blood bicarbonate decreased, blood urea increased, cryptogenic organizing pneumonia, diffuse alveolar damage, fungal infection

, haematocrit decreased, haemoglobin decreased, hypotension. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TRISENOX, KETOCONAZOLE, ACYCLOVIR, ATENOLOL, SYNTHROID, VITAMINS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5088633-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Female patient, 75 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, cardio-respiratory arrest, fluid overload, haematocrit decreased, haemoglobin decreased, hypoglycaemia, hypotension. Mylotarg dosage: 18 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with INSULIN HUMULIN, LASIX, LOPRESSOR, SYNTHROID, PREMARIN, GLIPIZIDE, ACYCLOVIR. Patient died on 05/18/2002.

Mylotarg Side Effects Report #4780622-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 12, 2005. Female patient, 75 years of age, weighting 191.2 lb, was diagnosed with acute myeloid leukaemia, leukaemia recurrent, herpes virus infection and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiomegaly, chest pain

, chills, haematocrit decreased, haemoglobin decreased, herpes virus infection. Mylotarg dosage: 16 MG 1X PER 1 DAY, INTRAVENOUS; 16 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5062296-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2006. Male patient, 73 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood chloride decreased, haematocrit decreased, haemoglobin decreased, nausea

, platelet count decreased, red blood cell count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, PROTONIX, DIOVAN, ACYLOVIR, REGLAN, DIFLUCAN, CELEXA, ATIVAN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4949574-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, central line infection, chills, disease progression, dyspnoea, febrile neutropenia, haematocrit decreased, haemoglobin decreased, infusion related reaction. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4967135-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2006. Male patient, 73 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection

, blood chloride decreased, haematocrit decreased, haemoglobin decreased, nausea

, platelet count decreased, red blood cell count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, PROTONIX, DIOVAN, ACYCLOVIR, REGLAN, DIFLUCAN, CELEXA, ATIVAN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4843534-8
Mylotarg side effect was reported by a Pharmacist from UNITED STATES on Nov 16, 2005. Male patient, 71 years of age, weighting 155.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bone marrow failure, condition aggravated, epistaxis, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, neutrophil count decreased, orthostatic hypotension, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with THEOPHYLLINE, IMDUR, ALLOPURINOL, CARAFATE, CEFEPIME, FLAGYL, VANCOMYCIN, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5064306-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, 69 years of age, weighting 169.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute prerenal failure, cardiovascular disorder, chills, haematocrit decreased, haemoglobin decreased, hepatic failure, herpes simplex

, mucosal inflammation, neutropenic sepsis. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 04/28/2004.

Mylotarg Side Effects Report #4959814-1
Mylotarg side effect was reported by a Health Professional from JAPAN on Mar 20, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, platelet count decreased, red blood cell count decreased, sepsis

. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with FAMOTIDINE, PANTOSIN, MAGNESIUM OXIDE, LASIX, KYTRIL, LOXONIN, MUCOSTA. Patient recovered.

Mylotarg Side Effects Report #5136060-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Male patient, 64 years of age, weighting 170.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacteraemia, blood pressure systolic decreased, central line infection, fungal infection

, haematocrit decreased, haemoglobin decreased, infusion related reaction, lung neoplasm, neutropenic sepsis. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4952639-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2004. Male patient, 61 years of age, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haematocrit decreased, haematoma, haemoglobin decreased, international normalised ratio increased, lung infiltration, lymphocyte count increased, platelet count decreased, pleural effusion. Mylotarg dosage: unknown. During the same period patient was treated with PREVACID, VALTRAX, LEVAQUIN, FLEXERIL, ATENOL, ALLOPURINOL, ALLEGRA. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4982895-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Female patient, 61 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory failure, blood sodium increased, chills, convulsion, depressed level of consciousness, dialysis

, haematocrit decreased, haemoglobin decreased, haemolytic uraemic syndrome. Mylotarg dosage: 16.5 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ANTIBIOTICS. Patient was hospitalized. Patient died on 05/10/2005.

Mylotarg Side Effects Report #4703515-1
Mylotarg side effect was reported by a Consumer or non-health professional from on June 22, 2005. Male patient, 60 years of age, weighting 158.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspiration, chest x-ray abnormal, confusional state, cytomegalovirus infection

, disorientation, epistaxis, fungal infection

, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 4 MG/M^2; INTRAVENOUS. During the same period patient was treated with PREDNISONE, MYCOPHENOLATE MOFETIL, DAPSONE, CIPROFLOXACIN, VALACYCLOVIR, CYCLOSPORINE, PRILOSEC. Patient was hospitalized. Patient died on 01/12/2001.

Mylotarg Side Effects Report #4736479-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2005. Male patient, 60 years of age, weighting 158.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspiration, cerebral haemorrhage, confusional state, cytomegalovirus infection

, disease progression, disorientation, epistaxis, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 4 MG/M^2, INTRAVENOUS. During the same period patient was treated with PREDNISONE, MYCOPHENOLATE MOFETIL, DAPSONE, CIPROFLOXACIN, VALACYCLOVIR, CYCLOSPORINE, PRILOSEC. Patient was hospitalized. Patient died on 01/12/2001.

Mylotarg Side Effects Report #4949643-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 186.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, catheter related infection, chills, dyspnoea, epistaxis, fatigue, febrile neutropenia, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4928865-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 15, 2006. Female patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, liver abscess, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with CEFPIROME, MINOPHAGEN C, FUNGUARD, CIPRO, NEUTROGIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4974413-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 30, 2006. Female patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, leukopenia, liver abscess, platelet count decreased, red blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with FUNGUARD. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5026914-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 02, 2006. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacterial infection

, blood creatinine decreased, c-reactive protein increased, haematocrit decreased, haemoglobin decreased, platelet count decreased, sepsis

. Mylotarg dosage: A SINGLE 9MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with TIENAM, AMIKACIN SULPHATE, PRODIF. Patient died.

Mylotarg Side Effects Report #4688233-0
Mylotarg side effect was reported by a Health Professional from on May 31, 2005. Female patient, 54 years of age, weighting 148.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cholelithiasis, haematocrit decreased, haemoglobin decreased, neutropenia, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 10.26 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5101949-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 25, 2006. Female patient, 53 years of age, weighting 154.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, back pain

, blood alkaline phosphatase increased, blood bilirubin increased, fatigue, febrile neutropenia, haematocrit decreased, insomnia, musculoskeletal chest pain. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEXAPRO, ACYCLOVIR, ZOFRAN, CHLORIDE, POLYVINYL ALCOHOL, PHENERGAN, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4757067-0
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 18, 2005. Male patient, 51 years of age, weighting 153.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blast cell proliferation, body temperature decreased, cardiac failure congestive, dilatation atrial, febrile neutropenia, haematocrit decreased, haemoglobin decreased, interstitial lung disease. Mylotarg dosage: 9 MG/M^2 1X PER 1DAY, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE. Patient was hospitalized. Patient died on 08/04/2003.

Mylotarg Side Effects Report #4910442-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 29, 2003. Male patient, 51 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood culture positive, enterobacter infection, gangrene, haematocrit decreased, hypotension, loss of consciousness, neutropenia, platelet count decreased. Mylotarg dosage: 6MG/M2, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUICIN. Patient was hospitalized. Patient died on 01/14/2003.

Mylotarg Side Effects Report #4698709-8
Mylotarg side effect was reported by a Consumer or non-health professional from on June 10, 2005. Female patient, 48 years of age, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cells present, febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased. Mylotarg dosage: 15.4 MG 1X PER 1 DAY, INTRAVENOUS; 15.3 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4728288-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 15, 2005. Female patient, 48 years of age, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased. Mylotarg dosage: 15.4 MG 1X PER 1 DAY; INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4951681-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 48 years of age, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, infusion related reaction, platelet count decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4978312-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2006. Female patient, 48 years of age, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, haematocrit decreased, haemoglobin decreased, infusion related reaction, marrow hyperplasia, nausea

, platelet count decreased, pyrexia. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4952755-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2004. Male patient, 45 years of age, weighting 160.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, ascites, blood alkaline phosphatase increased, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, hepatic failure, jaundice

, melaena. Mylotarg dosage: 16.2 MG X1 PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, DIFLUCAN, BACTRIM, PROGRAF, ACYCLOVIR, TYLENOL W, SPORANOX. Patient was hospitalized. Patient died on 06/26/2002.

Mylotarg Side Effects Report #4948795-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 34 years of age, weighting 194.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain

, blast cells present, chills, condition aggravated, diarrhoea, dyspnoea, haematocrit decreased, haemoglobin decreased, hypotension. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5102976-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2006. Female patient, 31 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: body temperature increased, disease progression, gastrointestinal haemorrhage, glucose urine present, haematocrit decreased, haemoglobin decreased, hyperglycaemia, hypernatraemia, hypertension. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CLINDAMYCIN, TIENAM. Patient died.

Mylotarg Side Effects Report #5046917-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 22, 2006. Female patient, 31 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, gastrointestinal haemorrhage, glucose urine present, haematocrit decreased, haemoglobin decreased, hyperglycaemia, hypernatraemia, hypertension. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE. During the same period patient was treated with CLINDAMYCIN, TIENAM. Patient died.

Mylotarg Side Effects Report #4958939-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Female patient, 28 years of age, weighting 151.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacteria blood identified, bacterial infection

, cholecystitis, culture positive, disseminated intravascular coagulation, enterococcal infection, haematocrit decreased, haemoglobin decreased, klebsiella infection. Mylotarg dosage: A SINGLE 6 MG/M^2 DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNOMYCIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5313880-2
Mylotarg side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pneumonia

, pyrexia, red blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, SIGMART, FRANDOL, HERBESSER, PURSENNID, GASTER, DIFLUCAN. Patient died on 03/10/2007.

Mylotarg Side Effects Report #5391478-8
Mylotarg side effect was reported by a Physician from JAPAN on July 11, 2007. Male patient, weighting 141.1 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, pyrexia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: c-reactive protein increased, haematocrit decreased, haemoglobin decreased, neutrophil count decreased, platelet count decreased, red blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FLUTIDE DISKUS, ALOSENN, FUNGUARD, FLUCONAZOLE, MAXIPIME, DORZOLAMIDE. Patient recovered.

Mylotarg Side Effects Report #5426236-9
Mylotarg side effect was reported by a Physician from JAPAN on Aug 17, 2007. Male patient, weighting 141.1 lb, was diagnosed with acute myeloid leukaemia, pyrexia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: c-reactive protein increased, haematocrit decreased, haemoglobin decreased, neutrophil count decreased, platelet count decreased, red blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FLUTIDE DISKUS, MAXIPIME, BAKTAR, FLUCONAZOLE, AMLODIPINE, ALOSENN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4694822-X
Mylotarg side effect was reported by a Consumer or non-health professional from on June 08, 2005. Female patient, 76 years of age, weighting 104.1 lb, was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg and haematocrit decreased

SideEffects101.com

Mylotarg and haematocrit decreased Patient Reports February 12, 2012

side effects of Mylotarg